Gaviscon and Progesterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Progesterone (progesterone). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Progesterone. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

On Jul, 26, 2026

25 people who take Gaviscon and Progesterone together, and have interactions are studied.

Gaviscon and Progesterone drug interactions.

What are the common drug interactions of Gaviscon and Progesterone, by gender? *:

female:

Anxiety
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Abnormal weight gain
Groin pain
Hot flush (sudden feelings of heat)
Joint stiffness
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Menopausal symptoms

male:

n/a

What are the common drug interactions of Gaviscon and Progesterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Live birth
Maternal exposure during pregnancy (use of substance during pregnancy)
Pain in extremity
Placental disorder
Respiratory tract infection
Retained placenta or membranes (placenta in uterus)

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

Asthma
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cystitis (inflammation of the wall of the bladder)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Urinary tract infection
Chronic kidney disease
Febrile neutropenia (fever with reduced white blood cells)
Renal failure (kidney dysfunction)

60+:

Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Anxiety
Pain
Sleep disorder
Vulvovaginal dryness
Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Acute respiratory distress syndrome

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 32.00%
Vulvovaginal Dryness: 7 people, 28.00%
Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 6 people, 24.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 24.00%
Injection Site Reaction: 6 people, 24.00%
Head Injury: 6 people, 24.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 24.00%
Arrhythmias (irregular heartbeat): 6 people, 24.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 24.00%
Swallowing Difficulty: 6 people, 24.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and Progesterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously